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Plasma lipid levels are used as both clinical predictors and as therapeutic targets for cardiovascular disease. As such, 
substantial effort has been expended to identify genetic factors 
that influence plasma lipid levels.1–4 A key genetic determinant 
of lipid levels is male–female sex. Inherent sex differences in 
lipid levels have led to distinct standards for the diagnosis 
of hyperlipidemia in men and in women, but the underlying 
mechanisms that contribute to differences in lipid levels are 
not well understood. Men tend to have higher low-density 
lipoprotein (LDL) and triglyceride levels, and lower high-den-
sity lipoprotein (HDL) levels, than premenopausal women.5,6 
After menopause, women often have proatherogenic lipid lev-
els that reach or exceed those in men.5–7 These observations 
support a role for gonadal hormones as a key determinant of 
sexual dimorphism in lipid levels.7 But the relationship seems 
to be complex, with postmenopausal hormone therapy afford-
ing greatest cardioprotection in women when provided within 
10 years of menopause.8–12 Other studies suggest that the basis 
for sex differences in lipid metabolism are multifactorial, with 
gonadal hormones acting together with direct or indirect con-
tributions from other sex-specific factors.6
Besides gonadal secretions, another fundamental differ-
ence between males and females is the presence of an XX 
or XY sex chromosome complement. Differences because of 
gonadal sex versus sex chromosome complement have been 
difficult to discriminate because, typically, female gonads 
occur together with XX chromosomes, and male gonads with 
XY chromosomes. In this study, we used the four core geno-
types (FCG) mouse model to identify independent effects on 
plasma lipid levels of gonadal sex (testes versus ovaries) and 
sex chromosome complement (XX versus XY). The FCG 
model consists of 4 types—or sexes—of mice: gonadal male 
mice with either XX or XY sex chromosomes, and gonadal 
female mice with XX or XY sex chromosomes.13–15 In the FCG 
model, the Y chromosome is deleted for the testis-determin-
ing Sry gene, which is provided instead by an Sry transgene 
inserted into an autosome. As a result, gonadal sex segregates 
independently from the sex chromosome complement. Sex 
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Objective—The molecular mechanisms underlying sex differences in dyslipidemia are poorly understood. We aimed to 
distinguish genetic and hormonal regulators of sex differences in plasma lipid levels.
Approach and Results—We assessed the role of gonadal hormones and sex chromosome complement on lipid levels using 
the four core genotypes mouse model (XX females, XX males, XY females, and XY males). In gonadally intact mice 
fed a chow diet, lipid levels were influenced by both male–female gonadal sex and XX–XY chromosome complement. 
Gonadectomy of adult mice revealed that the male–female differences are dependent on acute effects of gonadal 
hormones. In both intact and gonadectomized animals, XX mice had higher HDL cholesterol (HDL-C) levels than XY 
mice, regardless of male–female sex. Feeding a cholesterol-enriched diet produced distinct patterns of sex differences 
in lipid levels compared with a chow diet, revealing the interaction of gonadal and chromosomal sex with diet. Notably, 
under all dietary and gonadal conditions, HDL-C levels were higher in mice with 2 X chromosomes compared with mice 
with an X and Y chromosome. By generating mice with XX, XY, and XXY chromosome complements, we determined 
that the presence of 2 X chromosomes, and not the absence of the Y chromosome, influences HDL-C concentration.
Conclusions—We demonstrate that having 2 X chromosomes versus an X and Y chromosome complement drives 
sex differences in HDL-C. It is conceivable that increased expression of genes escaping X-inactivation in XX mice 
regulates downstream processes to establish sexual dimorphism in plasma lipid levels.  (Arterioscler Thromb Vasc Biol. 
2015;35:1778-1786. DOI: 10.1161/ATVBAHA.115.305460.)
Key Words: diet ◼ female ◼ HDL cholesterol ◼ male ◼ mice 
Received on: February 10, 2015; final version accepted on: June 8, 2015.
From the Molecular Biology Institute (J.C.L., K.R.), Department of Integrative Biology and Physiology (X.C., A.P.A.), Laboratory of Neuroendocrinology 
of the Brain Research Institute (X.C., A.P.A.), Department of Human Genetics, David Geffen School of Medicine (C.P., K.R.), and Department of Medicine, 
David Geffen School of Medicine (K.R.), University of California, Los Angeles; and Children’s Hospital Oakland Research Institute, California (M.S.B., 
B.H., M.N.O.).
The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/doi:10.1161/ATVBAHA.115.305460/-/DC1.
Correspondence to Karen Reue, PhD, Department of Human Genetics, David Geffen School of Medicine at UCLA, 695 Charles E. Young Dr S, Los 
Angeles, CA 90095. E-mail reuek@ucla.edu
Increased High-Density Lipoprotein Cholesterol Levels  
in Mice With XX Versus XY Sex Chromosomes
Jenny C. Link, Xuqi Chen, Christopher Prien, Mark S. Borja, Bradley Hammerson,  





 http://ahajournals.org by on N
ovem
ber 3, 2020
Link et al  Increased HDL-C in Mice With 2 X Chromosomes  1779
differences observed between gonadal males and females can 
be attributed to the action of gonadal hormones, whereas differ-
ences between XX and XY mice can be ascribed to the number 
of X or Y chromosomes. In addition, by comparing intact and 
gonadectomized mice, further distinction can be made between 
the effects of gonadal hormones during development and those 
resulting from acute effects of hormones in adulthood.
We recently used the C57BL/6 FCG mouse model to 
determine how sex chromosome complement contributes to 
sex differences in metabolic traits, such as body weight, adi-
posity, and hepatic lipid content. Specifically, when gonadec-
tomized as adults to remove acute gonadal effects, XX mice 
have increased obesity and fatty liver compared with XY 
mice, regardless of whether they originally had male or female 
gonads.16 We hypothesized that sex chromosome complement 
may also contribute to sex differences in plasma lipid profiles. 
Here, we report that gonadal hormones and sex chromosome 
complement have independent effects on plasma lipoprotein 
levels. These results have implications for understanding 
the basis for sex differences in plasma lipid levels, and may 
inform about key risk factors in the metabolic syndrome.
Materials and Methods
Materials and Methods are available in the online-only Data 
Supplement.
Results
Acute Gonadal Hormones and the Sex Chromosome 
Complement Influence Plasma Lipid Levels
To analyze sex differences, we measured fasting lipid levels 
(total cholesterol, HDL cholesterol [HDL-C], triglyceride, and 
free fatty acids [FFA]) in the 4 genotypes of FCG mice. We 
defined HDL-C levels as the cholesterol present in particles 
that lack apolipoprotein B (apoB), and LDL/VLDL (very low-
density lipoprotein) cholesterol levels as that from all non-
HDL particles (Materials and Methods section of this article). 
Statistical analyses were performed by 2-way ANOVA, with 
gonadal sex (male or female) and sex chromosome comple-
ment (XX or XY) as covariates.
We first assessed plasma lipid levels in gonadally intact 
mice fed a chow diet. Total cholesterol levels were similar to 
those reported previously for C57BL/6 mice, with HDL-C 
accounting for the majority of plasma cholesterol, as is 
typical in mice.17,18 Compared with females, male mice had 
higher levels of total and HDL-C, as well as triglyceride and 
FFA (Figure 1A). Males also had slightly higher amounts of 
unesterified cholesterol (UC in Figure 1). Notably, however, 
animals of both gonadal sexes with XX chromosomes had 
Nonstandard Abbreviations and Acronyms
apoB apolipoprotein B
FCG four core genotypes
FFA free fatty acid
HDL high-density lipoprotein
HDL-C high-density lipoprotein cholesterol
LDL low-density lipoprotein
LDL-C low-density lipoprotein cholesterol
Figure 1. Plasma lipid levels are regulated by both gonadal sex and sex chromosome complement. A and B, Concentrations of total cho-
lesterol (TC), unesterified cholesterol (UC), high-density lipoprotein (HDL) cholesterol, triglycerides (TG), and free fatty acids (FFA) were 
measured in 7.5-month-old gonadally intact (A) and gonadectomized (GDX; B). Four core genotypes mice fed a standard chow diet (n=8). 
Low-density lipoprotein (LDL) cholesterol values were calculated by subtracting HDL from TC. Values represent the mean±SD. Significant 
comparisons for sex chromosome complement and for gonadal sex are denoted by brackets. A significant interaction of sex chromo-
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20% higher HDL-C levels than XY mice (P<0.02). These 
results indicate that male–female gonads are a determinant of 
sex differences in plasma lipid levels, but also reveal that the 
sex chromosome complement influences HDL-C levels, even 
in the presence of normal gonadal hormone levels.
The sex differences in lipid levels that were observed 
between males and females could result from either long-
term or short-term effects of gonadal secretions.19 To dis-
tinguish between these, we gonadectomized mice after 
they reached adulthood (75 days of age) and determined 
lipid levels 5 months later, at which point acute effects of 
gonadal hormones should be absent, but long-term effects 
might persist. Gonadectomized mice did not exhibit the 
male–female differences in lipid levels that were present 
in gonadally intact mice indicating that much of the male–
female dimorphism in plasma lipid levels is related to acute 
effects of gonadal secretions. However, as observed in 
intact mice, HDL and UC levels were higher in XX com-
pared with XY mice (P<0.0003 and P<0.04), regardless of 
original gonad type (Figure 1B). After gonadectomy, total 
cholesterol levels and FFA levels were also higher in XX 
than in XY mice (P<0.007 and P<0.003). Thus, the effects 
of XX chromosome complement on HDL and UC levels 
are robust, occurring in both the presence and absence of 
gonadal secretions, and gonadectomy exposes underlying 
effects of chromosome complement on total cholesterol and 
FFA levels.
Lipoprotein Composition Differs 
in XX and XY Mice
As described above, HDL-C values (determined after frac-
tionation of apoB-containing lipids) are higher in mice with 
XX compared with XY chromosome complement. We won-
dered if sex chromosome complement influences HDL char-
acteristics, such as particle size, apolipoprotein content, or 
HDL–apolipoprotein (apo)A-I exchange activity (a measure 
of HDL function). To assess whether HDL size distribution 
differs among the FCG genotypes, we fractionated plasma 
samples by fast protein liquid chromatography and quantified 
cholesterol content of the resulting fractions. HDL-C peaks 
directly mirrored the results of biochemical fractionation, 
with highest HDL-C levels in the XX mice within each sex 
(XX males>XY males and XX females>XY females), and 
higher levels in males than in females in gonadally intact mice 
(Figure 2A). In mice that had been gonadectomized as adults, 
the HDL-sized particles were more abundant in XX compared 
with XY mice, and male–female differences were not detect-
able (Figure 2B). Minor sex differences were observed in 
cholesterol levels in LDL-sized particles, with slightly higher 
levels in females than in males in both intact and gonadecto-
mized mice (Figure 2A and B).
We assessed the relative plasma apolipoprotein levels 
in plasma from the FCG mice. Consistent with the higher 
HDL-C levels in intact male mice, levels of the major HDL 
apolipoprotein, apoA-I, were slightly higher in males than 
Figure 2. High-density lipoprotein (HDL) lipopro-
tein composition and apoA-I exchange activity 
is influenced by sex. Plasma was collected from 
7.5-month-old gonadally intact (A and D) and 
gonadectomized (GDX; B and E) chow-fed mice. 
A and B, Three representative plasma samples 
from each genotype were pooled and assayed 
using fast protein liquid chromatography.  
C, Plasma levels of apolipoproteins were quanti-
fied by immunoblot densitometry. Direction of 
statistically significant comparisons for gonadal 
sex and for sex chromosomes are shown. 
A significant interaction of sex chromosome 
complement and gonadal sex is denoted by 
“Interaction.” D and E, HDL–apoA-I dissociation 
activity was measured by electron paramagnetic 
resonance and represented as % response. Val-
ues represent the mean±SD. *P≤0.05, **P≤0.01, 
***P≤0.001. F indicates gonadal female; LDL, 
low-density lipoprotein; M, gonadal male; n.s., 
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in females (P<0.02; Figure 2C; Table I and Figure I in the 
online-only Data Supplement). A similar male–female dif-
ference was observed for apoE, a component of multiple 
lipoprotein classes (P<0.0005). Apolipoprotein levels were 
also influenced by sex chromosome complement. The levels 
of apoA-I, apoA-IV, and apoE were higher in XY compared 
with XX mice of both gonadal sexes (P<0.02, P<0.03, and 
P<0.01, respectively). This was unexpected, given the higher 
HDL-C levels in XX compared with XY mice. Gonadectomy 
abolished the male–female differences in apolipoprotein 
levels, but maintained the higher apoA-I levels in XY com-
pared with XX mice (P<0.006). Removal of the gonads also 
uncovered interactions between sex chromosome comple-
ment and the original gonadal sex (Figure 2C; Table I in 
the online-only Data Supplement). ApoB levels were low in 
all chow-fed mice, and neither apoB nor apoA-II levels dif-
fered among the 4 genotypes (Table I and Figure I in the 
online-only Data Supplement). Overall, our results reveal 
complex effects of sex chromosome complement on plasma 
lipoprotein composition, with XX chromosome complement 
favoring higher HDL-C content, but lower total levels of apo-
lipoproteins that are often associated with HDL, including 
apoA-I and apoA-IV.
The lower apolipoprotein/cholesterol ratio of HDL from 
XX compared with XY mice could influence HDL function. 
One assessment of HDL function is the degree to which apoA-
I present on HDL can be dissociated from the lipoprotein 
particle (HDL–apoA-I exchange).20 A reduced HDL–apoA-I 
exchange rate correlates with metabolic syndrome and acute 
coronary syndrome in humans, and with increased atheroscle-
rotic plaque burden in rabbits.21 We assessed the HDL–apoA-I 
exchange rate using site-directed spin-label electron paramag-
netic resonance.21 In both intact and gonadectomized mice, the 
HDL–apoA-I exchange activity in plasma mirrored HDL-C 
concentrations, with male>female in intact mice (P=0.001) 
and XX>XY in gonadectomized mice (P<0.003; Figure 2D 
and 2E). Thus, sex differences in HDL–apoA-I exchange rates 
parallel those in HDL-C levels, and are influenced by both 
gonadal and chromosomal sex determinants.
Sex Chromosome–Diet Interactions Influence 
Cholesterol Levels and HDL Activity
Lipid levels are highly responsive to diet. We investigated 
the factors underlying sexual dimorphism in lipid levels in 
response to dietary cholesterol by feeding FCG mice, a diet 
containing 1.25% cholesterol (in contrast to 0.02% in chow). 
As expected, the cholesterol-enriched diet caused substantial 
increases in the absolute levels of total and LDL cholesterol 
(LDL-C) in all genotypes compared with levels in mice fed 
the chow diet. Although both sex chromosomes and gonadal 
sex influenced lipid levels on a high cholesterol diet, specific 
effects differed from chow diet. As we observed on chow diet, 
sex chromosome complement remained an important deter-
minant of HDL-C levels, with XX>XY (Figure 3A). Unlike 
chow diet, however, sex chromosome complement also influ-
enced triglyceride and FFA levels, with XY>XX. HDL and 
UC levels were both influenced by gonadal sex in intact mice 
fed a cholesterol-enriched diet, with female>male. Thus, in 
some cases, the determinants of sexual dimorphism in lipid 
traits are responsive to diet.
Removal of the acute effects of gonadal secretions by 
gonadectomy of adult mice produced unique patterns of lipid 
Figure 3. Diet interacts with gonadal sex and sex chromosome complement to modulate plasma lipid levels. A and B, Concentrations of 
total cholesterol (TC), unesterified cholesterol (UC), high-density lipoprotein (HDL) cholesterol, triglycerides (TG), and free fatty acids (FFA) 
were determined in 7.5-month-old gonadally intact (A) and GDX (B) FCG mice fed a high cholesterol diet (HCD, n=4–10). Low-density 
lipoprotein (LDL) cholesterol values were calculated by subtracting HDL from TC. Values represent the mean±SD. Significant compari-
sons for sex chromosome complement and for gonadal sex are denoted by brackets. A significant interaction of sex chromosome com-
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levels among the 4 genotypes compared with chow diet or 
intact mice fed cholesterol diet. HDL-C and UC levels were 
higher in XX compared with XY mice (Figure 3B). Thus, 
HDL and UC cholesterol levels were consistently influenced 
by sex chromosome complement across diets (chow and high 
cholesterol) and gonadal state (intact and gonadectomized). 
Unexpectedly, in gonadectomized mice, the cholesterol diet 
uncovered male–female differences in several lipid traits that 
were not apparent in gonadally intact mice. Thus, males had 
higher levels than females of total cholesterol, LDL-C, UC, 
triglyceride, and FFA (Figure 3B). Interestingly, the only 
condition examined in which LDL-C levels exhibited sexual 
dimorphism was in mice gonadectomized and fed a choles-
terol-enriched diet. Detection of male–female lipid level dif-
ferences in gonadectomized mice suggests a role for either 
long-lasting (organizational) effects of gonadal hormones 
present in early life, or an effect of Sry acting outside of the 
gonads. Furthermore, the emergence of male–female dimor-
phism in cholesterol traits exclusively in gonadectomized ani-
mals suggests that acute effects of gonadal secretions in intact 
mice may counteract these organizational hormone effects.
As described above, the presence of XX sex chromo-
somes was associated with higher HDL-C levels than XY 
chromosome complement. On the cholesterol-enriched diet, 
HDL-C levels were ≈60% higher in XX than in XY mice 
in both intact and gonadectomized states (Figure 3). In the 
intact mice on both diets, the sex chromosome effect was 
overlaid with male–female sex differences. The XX>XY dif-
ferences in HDL-C levels of mice fed a cholesterol-enriched 
diet were recapitulated when HDL particles were defined 
by size via fast protein liquid chromatography fractionation 
(Figure 4A and 4B). Analysis of apolipoprotein content on the 
cholesterol-enriched diet showed XX>XY for several HDL 
apolipoproteins (apoA-I, apoA-II, and apoA-IV) in intact 
mice; female>male effects were also evident for apoA-IV 
and apoE (Figure 4C; Table I and Figure I in the online-only 
Data Supplement). In gonadectomized mice fed a cholesterol-
enriched diet, the sex chromosome effects on apolipoprotein 
content were less pronounced, but still apparent for apoA-II 
and apoE.
Assessment of HDL–apoA-I exchange activity revealed a 
strong effect of diet. On a chow diet, HDL activity in gonadally 
intact mice was higher in males than in females (Figure 2D); 
after cholesterol feeding, XX mice had higher HDL–apoA-I 
exchange activity than XY mice, and female mice had higher 
activity than males (Figure 4D). Gonadectomy in combina-
tion with dietary cholesterol reduced the absolute levels of 
HDL–apoA-I exchange activity compared with all other 
dietary–gonadal hormone conditions, particularly in females 
(Figure 4E); in chow-fed mice, gonadectomy reduced HDL–
apoA-I exchange activity only in males (Figure 2E). These 
results suggest that acute effects of gonadal hormones are a 
determinant of HDL–apoA-I exchange capacity, with distinct 
sexually dimorphic effects that respond to diet.
Figure 4. Diet interacts with sex to influence 
high-density lipoprotein (HDL) lipoprotein com-
position and apoA-I exchange activity. Plasma 
was collected from 7.5-month-old gonadally 
intact (A and D) and gonadectomized (GDX;  
B and E) mice fed the high cholesterol diet 
(HCD). A and B, Three representative plasma 
samples from each genotype were pooled 
and assayed using fast protein liquid chroma-
tography. C, Plasma levels of apolipoproteins 
were quantified by immunoblot densitometry. 
Direction of statistically significant comparisons 
for gonadal sex and for sex chromosomes 
are shown. A significant interaction of sex 
chromosome complement and gonadal sex is 
denoted by Interaction. D and E, HDL–apoA-I 
dissociation activity was measured by electron 
paramagnetic resonance and represented as 
% response and as activity per unit of HDL 
cholesterol. Values represent the mean±SD. 
*P≤0.05, **P≤0.01, †P≤0.0001. F indicates 
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Gene Expression Levels for Components 
of Cholesterol Synthesis and Metabolism 
Do Not Explain Sex Differences in 
Plasma Cholesterol Levels
In all dietary and gonadal conditions examined here, HDL-C 
levels were higher in mice with XX compared with XY chro-
mosome complement. To investigate potential mechanisms, 
we examined hepatic gene expression levels for key players in 
cholesterol synthesis and metabolism. These included deter-
minants of cholesterol biosynthesis (Hmgcr and Mvk), cellular 
lipoprotein uptake (Ldlr and Scarb1), cholesterol conversion 
to bile acids (Cyp7a1, Cyp8b1, and Cyp27a1), and HDL lipid 
accumulation (Lcat, Pltp, Abca1, and Abcg1). We searched 
for patterns of gene expression that mirrored the elevated 
HDL-C levels in XX compared with XY genotypes across the 
4 cohorts of mice, all of which had higher HDL-C levels in 
XX compared with XY mice. In some cases (eg, Pltp, Abcg1), 
male gonadal secretions appeared to inhibit gene expression, 
as increased expression of these genes was observed in chow-
fed males after gonadectomy. And although we identified 
some instances of XX versus XY differences in gene expres-
sion, we did not detect patterns that are likely to explain the 
elevated levels of HDL in XX compared with XY mice (Table; 
Figures II–IV in the online-only Data Supplement).
Differences in X Chromosome Gene Dosage 
Associate With Plasma HDL-C Levels
The association of HDL-C levels with XX chromosome 
complement suggests a mechanism that is directly related to 
the presence of a second X chromosome or the absence of 
a Y chromosome. To distinguish between these 2 possibili-
ties, we measured plasma lipid levels in a mouse model dif-
fering in the number of sex chromosomes.14,22 The abnormal 
Y* chromosome undergoes recombination with the X chro-
mosome to produce XX, XXY* (similar to XXY), and XY* 
(similar to XY) mice. Chow-fed, gonadectomized mice with 
2 X chromosomes (XX and XXY) had higher levels of total, 
Table.  Sex Differences in Hepatic Gene Expression
Chow Intact Chow GDX HCD Intact HCD GDX
Cholesterol synthesis and transport
  Abca1 M>F** n.s. F>M** XY>XX*
Int.**








  ApoB XX>XY** M>F* M>F† n.s.
  Hmgcr n.s. n.s. M>F**
XY>XX**
n.s.
  Lcat F>M* M>F* M>F† F>M*
XX>XY***
  Ldlr XX>XY* n.s. M>F† XX>XY*
  Lipc F>M*
Int.**
XX>XY** M>F† n.s.
  Mvk n.s. n.s. Int.* n.s.





  Scarb1 n.s. n.s. M>F** XX>XY*
Bile acid synthesis





  Cyp8b1 M>F**
XX>XY**
F>M** n.s. n.s.


























Hepatic gene expression was measured by quantitative polymerase chain 
reaction. P-values are represented by direction of sex difference and magnitude 
of significance. F indicates gonadal female; GDX, gonadectomized; HCD, high 
cholesterol diet; M, gonadal male; and n.s., not significant.
*P≤0.05, **P≤0.01, ***P≤0.001, †P≤0.0001, ‡P≤0.000001.
Figure 5. Elevated total and high-density lipoprotein (HDL) cho-
lesterol levels are associated with presence of 2 X chromosomes. 
Concentrations of total cholesterol (TC), unesterified cholesterol 
(UC), HDL cholesterol, triglyceride (TG), and free fatty acids (FFA) 
were measured in gonadectomized XY* chow-fed mice with the 
sex chromosome genotypes indicated (n=7–8). Low-density lipo-
protein (LDL) cholesterol values were calculated by subtracting 
HDL from TC. Values represent the mean±SD. Significant com-
parisons by 1-way ANOVA with Duncan multiple-comparison test 
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unesterified, and HDL-C than mice with a single X chromo-
some (XY; P<0.007, P<0.006, and P<0.04, respectively). The 
presence of the Y chromosome did not affect HDL-C levels 
(compare XX with XXY; Figure 5). By contrast, mice with 
a Y chromosome (XXY and XY) had higher LDL-C and tri-
glyceride levels than mice without a Y (P<0.03 and P<0.02, 
respectively), regardless of the number of X chromosomes. 
These data indicate that the presence of X and Y chromosomes 
have distinct effects on lipid species, with HDL-C influenced 
by the number of X chromosomes, and LDL-C influenced by 
the presence of the Y chromosome.
In general, dosage of X chromosome gene expression is 
normalized between XX and XY cells through inactivation 
of 1 X chromosome in XX cells. However, a small subset of 
genes escape X chromosome inactivation and exhibit higher 
expression levels in XX compared with XY cells.23 Genes 
that are well established to escape inactivation in both mice 
and humans include Ddx3x, Eif2s3x, Kdm5c, and Kdm6a. The 
expression levels of these genes have the potential to influ-
ence numerous downstream cellular processes through their 
roles as histone methylases (Kdm5c and Kdm6a), a DNA 
helicase (Ddx3x), and a translation initiation factor (Eif2s3x). 
To assess whether the X-inactivation escapee genes have 
enhanced expression levels in the 4 cohorts of mice stud-
ied here in a relevant metabolic tissue, we quantitated gene 
expression in liver of both intact and gonadectomized FCG 
mice on chow and high cholesterol diets. These genes were 
expressed at higher levels in XX mice compared with XY 
mice in nearly all cohorts (Table; Figure V in the online-only 
Data Supplement). In some cases, male–female dimorphism 
was also observed. The higher hepatic expression levels of X 
chromosome escapee genes in XX compared with XY liver 
raise the possibility that altered X chromosome gene dosage 
may contribute to sexual dimorphism in HDL-C levels, and 
probably other metabolic traits.
Discussion
We used the FCG mouse model to investigate the relative con-
tributions of gonadal secretions and sex chromosome comple-
ment to lipid levels. Using this model, we were able to detect 
sex chromosome complement as a determinant of sexual 
dimorphism in plasma lipids and in lipoproteins, particularly 
HDL-C.
In gonadally intact mice fed a chow diet, total and HDL-
C, as well as triglyceride and FFA levels, were higher in male 
mice (XX and XY) compared with female mice (XX and XY). 
In addition, HDL-C levels were influenced by sex chromosome 
complement, with higher levels in XX compared with XY mice. 
Thus, even in the presence of endogenous gonadal hormones, 
the effect of sex chromosomes on HDL-C levels was apparent. 
To further explore the influence of sex chromosome comple-
ment on lipid levels, we reduced hormone levels by gonadec-
tomy, which eliminated male–female differences observed in 
the intact mice, and amplified the XX versus XY effects on 
HDL-C levels. Gonadectomy also revealed that XX chromo-
some complement promotes higher total cholesterol and FFA 
levels. These results suggest that sex chromosome complement 
may become a particularly important determinant of lipid levels 
under conditions characterized by reduced gonadal hormones, 
such as middle age and postmenopause in humans.
We detected interactions between sex chromosome 
complement and diet. Gonadally intact XX mice fed a diet 
enriched in cholesterol had higher HDL-C levels than XY 
mice, as was observed in chow-fed mice. In addition, the cho-
lesterol-enriched diet brought out a novel sex chromosome 
effect on triglyceride and FFA levels, with higher levels in XY 
compared with XX mice. After gonadectomy, male mice had 
significantly higher levels than females for total cholesterol, 
LDL-C, triglyceride, and FFA. Because mice were gonadec-
tomized 5 months before lipid measurements, the observed 
male–female dimorphism must be a result of long-lasting (ie, 
organizational) effects of gonadal hormones, or nongonadal 
effects of Sry that are confounded with gonadal sex in this 
model. Together, our results indicate that sex differences in 
lipid levels are determined by a combination of hormonal 
and sex chromosome effects, and further, these differences 
are dependent on hormonal (high or low gonadal hormone 
concentrations) and diet (chow or high cholesterol) context 
(Figure 6A).
Regardless of diet or sex hormone milieu, HDL-C levels 
were elevated in mice with 2 X chromosomes. The potential 
benefits of elevated HDL-C levels include cholesterol efflux 
Figure 6. Factors influencing circulating high-
density lipoprotein (HDL) cholesterol. A, HDL 
cholesterol levels are higher in XX mice compared 
with XY mice, regardless of diet or sex hormone 
presence status. Male/female gonad status also 
influences HDL cholesterol levels under some con-
ditions. B, Plasma lipid other than HDL exhibit sex 
differences that depend on the diet and gonadal 
status. C, Mice with 2 X chromosomes have 
increased X escapee gene expression in metabolic 
tissues such as liver. These genes may influence 
several metabolic pathways to increase circulating 
HDL cholesterol. F indicates gonadal female; GDX, 





 http://ahajournals.org by on N
ovem
ber 3, 2020
Link et al  Increased HDL-C in Mice With 2 X Chromosomes  1785
from peripheral tissues, anti-inflammatory and antioxidative 
activities, and protection from infection.24,25 One metric of 
HDL activity that has been correlated with metabolic syn-
drome in humans and atherosclerosis in rabbits is the effi-
ciency of apoA-I exchange from HDL particles.21 We found 
that total HDL–apoA-I exchange activity was greater in XX 
mice than in XY mice, concordant with the increased HDL-C 
concentration in XX animals. These results suggest that XX 
chromosome complement may be a factor in determining both 
the levels and the protective activity of HDL.
By altering the number of X and Y chromosomes using 
the Y* mouse model, we determined that the presence of 2 X 
chromosomes is associated with increased HDL-C. We previ-
ously determined that the presence of 2 X chromosomes also 
leads to increased adiposity and fatty liver development on 
a high-fat diet.16 Thus, a future goal of broad importance is 
to understand how increased X chromosome dosage impacts 
metabolism. Here, we demonstrate that genes that escape 
X chromosome inactivation are expressed at higher levels 
in XX compared with XY tissues. The proteins encoded by 
these genes—which have roles in transcriptional regulation, 
RNA processing, and protein translation26–33—could conceiv-
ably influence lipid homeostasis (Figure 6B). The specific 
targets of X chromosome escapee gene activity are not well 
characterized at present, but ongoing studies are focused on 
their identification using large-scale transcriptional and epig-
enomic profiling.
Our data using the Y* mouse model revealed that in addi-
tion to effects of 2 X chromosomes on HDL-C levels, the pres-
ence of the Y chromosome may influence LDL-C levels. The 
Y chromosome has traditionally been viewed to harbor genes 
restricted to male gonad development and spermatogenesis. 
However, a recent study using consomic mouse strains with 
Y chromosomes derived from distinct inbred strains sug-
gests that genetic variation in Y chromosome genes influences 
plasma lipoprotein levels.34 The Y chromosome carries a set 
of genes that encode Y-specific proteins that are similar to 
paralogous genes on the X chromosome. These include the 
Y chromosome counterparts of the X chromosome escapee 
genes that exhibit increased dosage in mice with 2 versus a 
single X chromosome. In our study, all X and Y chromosomes 
were genetically identical, derived from the C57BL/6 strain, 
so that dosage alone was manipulated. It is interesting to spec-
ulate that both dosage and genetic variation in these X and Y 
chromosome genes may influence lipid levels.
Our genetic analysis of sexual dimorphism of lipopro-
tein levels has limitations imposed by the necessity of using 
a mouse model. It is well established that mice and humans 
differ in several aspects of lipoprotein metabolism.35 When fed 
a chow diet, mice carry approximately two thirds of plasma 
cholesterol in HDL particles, whereas humans carry a similar 
proportion in LDL particles. In this study, some mice were 
fed a cholesterol-enriched diet to increase the levels of LDL 
cholesterol, but because mice do not express cholesteryl ester 
transfer protein, which promotes the transfer of cholesteryl 
esters and triglycerides between lipoprotein particles, species 
differences in the metabolism of circulating lipoproteins per-
sist. Relevant to the effects of gonadal hormones on lipoprotein 
metabolism, it has been demonstrated that estradiol adminis-
tration produces different effects on HDL-C levels in mice and 
humans.36,37 Despite the known species differences in lipopro-
tein metabolism, the genetic loci that control HDL-C levels 
in mouse and human exhibit a substantial degree of overlap,38 
raising the possibility that fundamental genetic influences on 
lipoprotein physiology are shared between mouse and man.
In conclusion, our studies demonstrate that sexual dimor-
phism in lipid levels is a result of interactions between gonadal 
hormones, sex chromosome complement, and diet. The results 
further indicate that XX chromosome complement has a major 
influence on HDL-C levels, irrespective of diet or gonadal sta-
tus. Future studies with FCG mice will facilitate the identifica-
tion of sex-dependent biomarkers of disease associated with 
altered lipid levels, such as atherosclerosis. Such studies are 
crucial for improving the assessment and treatment of cardio-
vascular disease risk in men and women.
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Lipid profiles are an important indicator of the metabolic syndrome. Reports of sexually dimorphic low-density lipoprotein and high-density 
lipoprotein cholesterol levels suggest regulation by sex hormones. Here, we show that the sex chromosome complement is also a key fac-
tor in modulating plasma lipid levels. High-density lipoprotein cholesterol is consistently elevated in mice with 2 X chromosomes compared 
with mice with XY sex chromosomes, regardless of diet or circulating sex hormone levels. These findings are important for understanding 
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